Patents Assigned to LUNG THERAPEUTICS, LLC
  • Publication number: 20240269225
    Abstract: Provided herein are compositions comprising caveolin-1 (Cav-1) peptides. Further provided are methods of using the Cav-1 peptides for the treatment of lung infections or acute or chronic lung injury, particularly lung fibrosis.
    Type: Application
    Filed: February 6, 2024
    Publication date: August 15, 2024
    Applicants: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, LUNG THERAPEUTICS, LLC
    Inventors: Robert O. WILLIAMS, III, Alan B. WATTS, Yajie ZHANG, Sawittree SAHAKIJPIJARN, Dale CHRISTENSEN, John J. KOLENG